 | Up a level |
Canale, Fernando P; Neumann, Julia; von Renesse, Janusz; Loggi, Elisabetta; Pecoraro, Matteo; Vogel, Ian; Zoppi, Giada; Antonini, Gaia; Wolf, Tobias; Jin, Wenjie; Zheng, Xiaoqin; La Barba, Giuliano; Birgin, Emrullah; Forkel, Marianne; Nilsson, Tobias; Marone, Romina; Mueller, Henrik; Pelletier, Nadege; Jeker, Lukas T; Civenni, Gianluca; ... (2023). Proteomics of immune cells from liver tumors reveals immunotherapy targets. Cell genomics, 3(6), p. 100331. Elsevier 10.1016/j.xgen.2023.100331
Scheiner, Bernhard; Pomej, Katharina; Kirstein, Martha M; Hucke, Florian; Finkelmeier, Fabian; Waidmann, Oliver; Himmelsbach, Vera; Schulze, Kornelius; von Felden, Johann; Fründt, Thorben W; Stadler, Marc; Heinzl, Harald; Shmanko, Kateryna; Spahn, Stephan; Radu, Pompilia; Siebenhüner, Alexander R; Mertens, Joachim C; Rahbari, Nuh N; Kütting, Fabian; Waldschmidt, Dirk-Thomas; ... (2022). Prognosis of patients with hepatocellular carcinoma treated with immunotherapy - development and validation of the CRAFITY score. Journal of hepatology, 76(2), pp. 353-363. Elsevier 10.1016/j.jhep.2021.09.035
Pfister, Dominik; Núñez, Nicolás Gonzalo; Pinyol, Roser; Govaere, Olivier; Pinter, Matthias; Szydlowska, Marta; Gupta, Revant; Qiu, Mengjie; Deczkowska, Aleksandra; Weiner, Assaf; Müller, Florian; Sinha, Ankit; Friebel, Ekaterina; Engleitner, Thomas; Lenggenhager, Daniela; Moncsek, Anja; Heide, Danijela; Stirm, Kristin; Kosla, Jan; Kotsiliti, Eleni; ... (2021). NASH limits anti-tumour surveillance in immunotherapy-treated HCC. Nature, 592(7854), pp. 450-456. Springer Nature 10.1038/s41586-021-03362-0
